Previous Close | 30.54 |
Open | 30.49 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 29.95 - 30.92 |
52 Week Range | 23.41 - 47.74 |
Volume | |
Avg. Volume | 697,634 |
Market Cap | 2.609B |
Beta (5Y Monthly) | 0.82 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
With the data and support from the FDA, IDEAYA Biosciences has laid out how its Phase III trial of darovasertib will look.
The analysts covering IDEAYA Biosciences, Inc. ( NASDAQ:IDYA ) delivered a dose of negativity to shareholders today, by...